dioxiram has been researched along with dibenzothiazyl disulfide in 1 studies
| Studies (dioxiram) | Trials (dioxiram) | Recent Studies (post-2010) (dioxiram) | Studies (dibenzothiazyl disulfide) | Trials (dibenzothiazyl disulfide) | Recent Studies (post-2010) (dibenzothiazyl disulfide) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 58 | 0 | 17 |
| Protein | Taxonomy | dioxiram (IC50) | dibenzothiazyl disulfide (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.899 | |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 0.31 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.347 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.16 | |
| D(2) dopamine receptor | Homo sapiens (human) | 5.866 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.347 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.162 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.658 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.747 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 1.189 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.747 | |
| Melanocortin receptor 5 | Homo sapiens (human) | 3.9 | |
| Mu-type opioid receptor | Homo sapiens (human) | 3.113 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.851 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 1.243 | |
| C-C chemokine receptor type 2 | Homo sapiens (human) | 2.405 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.347 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 5.276 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.245 | |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 0.379 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Huang, YY; Li, J; Li, XK; Mao, F; Ni, SS; Ren, YL; Song, RR; Wan, J; Xu, YX; Zhang, C; Zhu, J | 1 |
1 other study(ies) available for dioxiram and dibenzothiazyl disulfide
| Article | Year |
|---|---|
Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Cysteine; Diabetes Mellitus, Type 2; Disulfides; Enzyme Inhibitors; Fructose-Bisphosphatase; Male; Mice; Structure-Activity Relationship | 2020 |